2-216464684-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014140.4(SMARCAL1):​c.2141+17T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00507 in 1,559,052 control chromosomes in the GnomAD database, including 232 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 135 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 97 hom. )

Consequence

SMARCAL1
NM_014140.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.578

Publications

1 publications found
Variant links:
Genes affected
SMARCAL1 (HGNC:11102): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1) The protein encoded by this gene is a member of the SWI/SNF family of proteins. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein shows sequence similarity to the E. coli RNA polymerase-binding protein HepA. Mutations in this gene are a cause of Schimke immunoosseous dysplasia (SIOD), an autosomal recessive disorder with the diagnostic features of spondyloepiphyseal dysplasia, renal dysfunction, and T-cell immunodeficiency. [provided by RefSeq, Jul 2008]
SMARCAL1 Gene-Disease associations (from GenCC):
  • Schimke immuno-osseous dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 2-216464684-T-C is Benign according to our data. Variant chr2-216464684-T-C is described in ClinVar as Benign. ClinVar VariationId is 260342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0759 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCAL1NM_014140.4 linkc.2141+17T>C intron_variant Intron 13 of 17 ENST00000357276.9 NP_054859.2
SMARCAL1NM_001127207.2 linkc.2141+17T>C intron_variant Intron 13 of 17 NP_001120679.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCAL1ENST00000357276.9 linkc.2141+17T>C intron_variant Intron 13 of 17 2 NM_014140.4 ENSP00000349823.4

Frequencies

GnomAD3 genomes
AF:
0.0230
AC:
3481
AN:
151390
Hom.:
135
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0783
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000285
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.000971
Gnomad OTH
AF:
0.0168
GnomAD2 exomes
AF:
0.00645
AC:
1610
AN:
249482
AF XY:
0.00495
show subpopulations
Gnomad AFR exome
AF:
0.0811
Gnomad AMR exome
AF:
0.00422
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000250
Gnomad NFE exome
AF:
0.000986
Gnomad OTH exome
AF:
0.00360
GnomAD4 exome
AF:
0.00313
AC:
4412
AN:
1407544
Hom.:
97
Cov.:
25
AF XY:
0.00275
AC XY:
1936
AN XY:
703544
show subpopulations
African (AFR)
AF:
0.0802
AC:
2585
AN:
32212
American (AMR)
AF:
0.00464
AC:
207
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25814
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39416
South Asian (SAS)
AF:
0.000176
AC:
15
AN:
85154
European-Finnish (FIN)
AF:
0.000155
AC:
8
AN:
51606
Middle Eastern (MID)
AF:
0.00177
AC:
10
AN:
5654
European-Non Finnish (NFE)
AF:
0.00120
AC:
1278
AN:
1064520
Other (OTH)
AF:
0.00528
AC:
309
AN:
58522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
190
380
570
760
950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0230
AC:
3486
AN:
151508
Hom.:
135
Cov.:
32
AF XY:
0.0218
AC XY:
1615
AN XY:
74014
show subpopulations
African (AFR)
AF:
0.0782
AC:
3215
AN:
41124
American (AMR)
AF:
0.0109
AC:
166
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5146
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4792
European-Finnish (FIN)
AF:
0.000285
AC:
3
AN:
10514
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.000971
AC:
66
AN:
67942
Other (OTH)
AF:
0.0166
AC:
35
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
164
328
493
657
821
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00546
Hom.:
21
Bravo
AF:
0.0259

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 02, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Schimke immuno-osseous dysplasia Benign:2
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.084
DANN
Benign
0.42
PhyloP100
-0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2066516; hg19: chr2-217329407; API